Select Page
Innovation Platform

Livegrow Bio

Startup - Founded in 2019Richland, WA, United States
Nutrients Nitrogen relatedPhosphorus relatedPotassium relatedOther nutrients
Technologies Other Fertilizer efficiency technologyBiostimulants & MicrobialsEnhanced Efficiency Fertilizers

LiveGrow Bio enables profitable scale-up of microbial biostimulants and biopesticides.

Our patented LiveGrow™ platform bypasses large-scale fermentation, cutting manufacturing costs by up to 95 % and delivering ≥ 2-year room-temperature shelf life at high CFU for both Gram-positive and Gram-negative strains. The modular process dramatically reduces CAPEX/OPEX while yielding metabolically active products that fit existing crop-input distribution channels and on-field equipment. Companies looking to commercialize microbes can book a complimentary consultation for rapid, low-cost formulation, shelf-life testing, and toll manufacturing, reaching market faster and at higher margins.

Your IFA Innovation Platform Profile

What collaboration are we looking for?

  • Investors – to finance new modular manufacturing plants based on our patented technology in the U.S. and key global markets.
  • Microbial discovery groups & research institutes – teams with Gram-positive or Gram-negative strains that need ≤ 3-month, low-cost formulation, shelf-life trials, and seamless scale-up at up to 95 % lower cost, with ≥ 2-year room-temperature stability at high CFU.
  • Food producers, grower cooperatives, and distribution networks – organizations aiming to bring custom, low-cost biologicals to their farmer supply chains, including region- and crop-specific strain isolation and accelerated field validation.

What solutions and opportunities are we offering?

We help companies commercialize microbial products profitably. Our patented LiveGrow™ platform cuts manufacturing costs by up to 95 %, provides ≥ 2-year room-temperature shelf life at high CFU, and converts even hard-to-formulate, non-spore-forming strains into high-margin products. Low-cost formulation and modular scale-up unlock crop- and region-specific biologicals for precision agriculture.

Crop-protection companies

  • We formulate any strain into a shelf-stable prototype in ≤ 3 months—at a fraction of industry cost—so you can run greenhouse and field trials with the launch-ready product while we run parallel shelf-life tests, saving years and millions in R&D.
  • We scale on low-CAPEX modular lines (no large fermenters), cutting manufacturing costs by up to 95 % and keeping ≥ 2-year stability, ready for existing distribution channels and strong margins.

 

Food producers & growers

  • We isolate field-specific microbes—or tap partner libraries—to create crop- and region-targeted biostimulants/biopesticides on an accelerated timetable.
  • We deliver testable batches within one season, then partner to manufacture at scale with the same cost-saving, long-lasting advantages, enabling precision biological solutions across your supply chain.

Maturity / funding

Seed

Additional Information

Funding received ($) and name of funders

$370,000 – Fuse Fund & MassChallenge Switzerland

... of which equity investment

$250,000 - Equity

... of which grants

$120,000 - Non-equity Award

Awards received, and brief description of the award(s)

• MassChallenge Switzerland 2023 – Platinum Award Winner (Grand Prize)
Selected as the winner sustainability startup from 1,200 global applicants; received CHF 100,000 equity-free award.
• Louis Dreyfus Company Climate Resilience Challenge 2023 – Global Top 6 Finalist
Recognized for delivering proven, climate-smart microbial solutions that boost yield, protect biodiversity, and reduce CO₂ across agricultural value chains.

Expected opening of next investment round

We are in an exclusive sixty day negotiation window with a private equity investor for a seed round of USD 5 to 12 million. Valuation will be finalized in the term sheet. Expected funding sought $5,000,000 USD

Expected funding sought from next investment round

$5,000,000 USD

Expected closing of next investment round

Q4 2025

Intellectual property & regulation

What is the IP status of your innovation(s)?

• Issued patents: United States Patent No. US 20200305438A1 and Mexican Patent No. 383312 covering our core microbial formulation platform (copies attached).

• Pipeline: Seven additional applications covering key commercialization trade secrets are drafted for filing post funding, ensuring global coverage in all major agricultural markets.

Contact details

Mr Andrey Pinchuk
CEO
Download Pitch / Introduction deck See the pitch presentation video